Bibliography
- BARNES PJ: The role of anticholinergics in chronic obstructive pulmonary disease. Am. J. Med. (2004) 117(Suppl.12A):24S-32S.
- KOUMIS T, SAMUEL S: Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin. Ther. (2005) 27(4):377-392.
- COULSON FR, FRYER AD: Muscarinic acetylcholine receptors and airway diseases. Pharmacol. Ther. (2003) 98(1):59-69.
- NORMAN P: Long acting muscarinic M3 receptor antagonists 1 GlaxoSmithKline. Expert Opin. Ther. Patents (2006) 16 preceding article.
- HEGDE SS, MAMMEN M, JASPER JR: Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. Curr. Opin. Investig. Drugs. (2004) 5(1):40-49.
- CLARK RB, ALLAL C, FRIEDMAN J et al.: Stable activation and desensitization of β2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite. Mol. Pharmacol. (1996) 49(1):182-189.
- EGLEN RM: Muscarinic receptor subtype pharmacology and physiology. Prog. Med. Chem. (2005) 43:105-136.
- ZLOTOS DP, BENDER W, HOLZGRABE U: Muscarinic receptor agonists and antagonists. Expert Opin. Ther. Patents (1999) 9(8):1029-1053
- NAITO R, TAKEUCHI M, MORIHIRA K et al.: Selective muscarinic antagonists. II.1) Synthesis and antimuscarinic properties of biphenylycarbamate derivatives. Chem. and Pharm. Bull. (1998) 46(8):1286-1294.
Patents
- THERAVANCE INC.: WO2005007645 (2005).
- THERAVANCE INC.: WO2005042514 (2005).
- THERAVANCE INC.: US20050277688 (2005).
- THERAVANCE INC.: US20060094878 (2006).
- ADVANCED MEDICINE, INC.: WO00142212 (2001).
- BOEHRINGER INGELHEIM PHARMA. GMBH: WO2004048373 (2004).
- GLAXO GROUP LTD: WO2004012684 (2004).